Valbiotis SA (FR:ALVAL) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Valbiotis, a French company focusing on the development of dietary supplements to combat metabolic disorders and cardiovascular diseases, has reported their total number of voting rights and shares as of June 30, 2024. The company, known for its innovative, plant-based approach, markets its products in France and seeks international licensing agreements. Valbiotis is part of the BPI Excellence network and has received European Union funding for research.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.